Purchase Order SPE2DP25V0555

Award Date 12/18/24
Potential Completion Date 2/16/25
Potential Value $1.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11207, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This federal contract award, valued at $1,878.72, was issued by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company and manufacturer of medical equipment, supplies, and pharmaceuticals. The contract is a firm-fixed-price purchase order for the supply of Moxifloxacin Hydrochloride, a pharmaceutical product. The contract has an ultimate completion date of February 16, 2025. SZY Holdings, LLC is a versatile defense contractor that provides a wide range of medical products to various DLA divisions, including Troop Support Medical, Aviation, Subsistence, Land and Maritime, and Construction and Equipment. This contract award is not designated as a set-aside and indicates the company's ability to compete successfully in open federal procurement markets. Additionally, SZY Holdings, LLC holds at least one notable Indefinite Delivery Contract (IDC) with the DLA Aviation, valued at $250,000 with a ceiling value of $250,000 over a five-year period, which demonstrates the company's capacity to secure and maintain long-term federal contract vehicles across different defense agency procurement channels.

Generated 3/19/25, 10:01 AM